Basic Toradol Information

• INN (International Nonproprietary Name): Ketorolac Tromethamine.
• Brand Names Available In Canada (English): Toradol; ketorolac generics marketed as ketorolac (tablets and injectable vials).
• ATC Code: M01AB15.
• Forms & Dosages: Tablet 10 mg; injection 10 mg/mL and 30 mg/mL; nasal spray Sprix (not widely marketed); ophthalmic solution 0.5% (Acular).
• Manufacturers In Canada (English): Hoffmann‑La Roche (Toradol) and generics from Sandoz, Teva, Mylan and other suppliers.
• Registration Status In Canada (English): Registered and available as a prescription product in Canada with Rx‑only status.
• OTC / Rx Classification: Prescription‑only (Rx). Not available over the counter.

Latest Research Highlights (Canadian + International, 2022–2025)

Patients ask whether Toradol really reduces the need for opioids after surgery and in the emergency department.

Recent Canadian and international evidence from 2022–2025 continues to show that ketorolac provides strong short‑term analgesia for moderate to severe acute pain, especially post‑operative and in emergency settings.

Meta‑analyses over this period confirm opioid‑sparing effects when IV or IM ketorolac is used as part of multimodal analgesia.

Safety summaries reinforce an increased risk of gastrointestinal bleeding and acute kidney injury when courses exceed recommended durations.

Canadian emergency department audits from 2022–2024 highlight effective use of parenteral ketorolac for renal colic and acute post‑op pain, often providing comparable analgesia to parenteral opioids.

International regulatory cautions, and the historical withdrawal in Germany, continue to inform conservative prescribing practices in Canada.

Clinical Effectiveness In Canada (Health Canada Monographs, DIN, Formularies)

People want to know whether toradol works faster than other options and whether hospitals and pharmacies use it the same way across provinces.

Health Canada lists ketorolac as an approved prescription NSAID and product monographs align with international dosing and safety limits, including a maximum recommended duration of five days for oral and parenteral therapy.

Published data from tertiary hospitals and academic centres across provinces report rapid analgesic onset for parenteral ketorolac, frequently within 30–60 minutes.

Multimodal pathways that include ketorolac commonly show meaningful reductions in opioid rescue requirements.

• Approved: Product Monograph — official Health Canada document describing indication, dosing and safety.
• DIN: Drug Identification Number — verify DIN when dispensing generics or brand formulations.
• Product Monograph: Official prescribing information supplied by the manufacturer and registered with Health Canada.

• Ontario Drug Benefit (ODB): Coverage for outpatient ketorolac is limited; inpatient hospital use commonly covered.
• BC PharmaCare: Outpatient coverage varies; hospital and surgical use is the typical setting for ketorolac.
• RAMQ (Quebec): Formularies restrict outpatient ketorolac; hospitals and ambulatory surgery remain primary users.

Indications And Expanded Uses (Approved Versus Off‑Label In Canadian Practice)

Patients commonly ask whether toradol can replace opioids for severe pain or be used for migraines.

Approved indications focus on short‑term management of moderate to severe acute pain, particularly post‑surgical pain.

Off‑label uses in Canadian emergency departments include single‑dose IV or IM ketorolac for severe migraine and renal colic when rapid parenteral analgesia is required.

• Approved Uses: Short‑term management of moderate to severe acute pain, post‑operative pain under supervision.
• Off‑Label Uses: Single‑dose IV/IM for acute migraine abortive therapy and renal colic in EDs.

Composition And Brand Landscape

Many patients ask whether they must take a brand‑name Toradol or if generics are the same.

Ketorolac tromethamine is the active ingredient in Toradol and in Canadian generic products.

Tablets and injectable vials are the primary forms stocked in Canada.

• Common strengths: 10 mg tablets; 10 mg/mL and 30 mg/mL injectable vials.

Contraindications And Special Precautions

People worry about whether Toradol is safe if they have a stomach ulcer, kidney disease or take blood thinners.

Absolute contraindications include a history of peptic ulcer or gastrointestinal bleeding, renal failure or severe renal impairment, known hypersensitivity to NSAIDs or ketorolac, active bleeding disorders, and use during labour or in the third trimester of pregnancy.

Relative contraindications require close monitoring and specialist input.

• Absolute Contraindications: History of peptic ulcer or GI bleeding; renal failure; known NSAID hypersensitivity; active bleeding; use in labour, pregnancy (especially third trimester); breastfeeding.
• Relative / Requires Close Monitoring: Elderly patients; cardiovascular disease; mild‑to‑moderate hepatic impairment; asthma that is NSAID‑sensitive; patients on anticoagulants.

Dosage Guidelines

Patients often ask what dose of toradol they were given in ED and how long they can safely take it.

Standard adult dosing is 10 mg orally every 4–6 hours, and IM/IV dosing of 10–30 mg every 6 hours with a maximum treatment duration of five days for oral or parenteral therapy.

Pediatric dosing is weight‑based and rarely used without specialist guidance.

• Elderly: Use lower doses (for example, 10 mg) and reduce total exposure due to higher adverse‑event risk.
• Renal Impairment: Generally avoid ketorolac; significant dose reduction or alternative analgesics recommended.
• Hepatic Impairment: Use caution and monitor liver enzymes; consider dose reduction.

Interactions Overview

Many callers ask whether they can take toradol with their other pills or have a drink while on it.

Ketorolac is a non‑selective COX inhibitor and interacts with several drug classes through increased bleeding risk, effects on renal function, and additive NSAID toxicity.

• Major Drug Interactions: Anticoagulants (higher bleeding risk); ACE inhibitors or diuretics (may reduce renal function); SSRIs (increased bleeding risk); other NSAIDs (additive GI and renal toxicity).
• Alcohol: Alcohol use increases the risk of GI bleeding and should be avoided during ketorolac therapy.
• OTC NSAIDs: Avoid concurrent ibuprofen or naproxen with ketorolac; always check with a pharmacist.

Interaction Severity Levels:

Severe: Combination with anticoagulants — avoid unless specialist approves and monitoring is in place.

Moderate: ACE inhibitors/diuretics — monitor renal function and blood pressure.

Mild: Short concurrent NSAID exposure — avoid additive doses and counsel accordingly.

Data Highlight: Anticoagulant plus ketorolac markedly increases bleeding risk and should generally be avoided unless expressly authorised by a specialist.

Cultural Perceptions And Patient Habits

Readers often report seeing strong praise for toradol on online forums, then worry about the risks they hear about.

Forum themes in Canadian communities commonly describe rapid relief after a single IV or IM dose and concerns about kidney and stomach side effects with repeated use.

• Theme: Fast acting and opioid‑sparing, frequently recommended for acute ED pain relief.
• Theme: Worry about kidney injury and stomach bleeds if repeat doses are used beyond guidelines.
• Theme: Preference for oral alternatives in remote or outpatient settings where parenteral options are limited.

Availability And Pricing Patterns (Pharmacies, Online, Cross‑Border)

People ask whether toradol is easy to get, how much it costs and whether it can be ordered online.

Toradol is a prescription‑only product in Canada, and tablets and injectable vials are stocked in hospitals and many community pharmacies depending on distributor supply and DIN availability.

In our online pharmacy, toradol is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

• Steps To Access Coverage: Contact your prescriber to document medical necessity for outpatient coverage.
• Steps To Access Coverage: Check Ontario Drug Benefit (ODB) if eligible for special authorization.
• Steps To Access Coverage: Contact BC PharmaCare for exceptional access or hospital discharge coverage questions.
• Steps To Access Coverage: Contact RAMQ for Quebec-specific formulary rules and exceptional access.

Comparable Medicines And Preferences

Many patients want to know how toradol stacks up against OTC pain relievers and opioids.

Competitors include ibuprofen, naproxen, diclofenac, paracetamol, triptans for migraine and opioids for severe pain.

• Pros: Rapid and potent analgesia for moderate–severe acute pain; opioid‑sparing when used appropriately.
• Cons: Higher risk of renal injury and GI bleeding with extended use; prescription only and restricted outpatient coverage in many provinces.

Frequently Asked Questions

Is Toradol available without prescription in Canada?

No.

Toradol is prescription‑only in Canada and a pharmacist will require a valid prescription and will check the DIN or product monograph before dispensing.

Follow‑up actions to obtain a prescription:

• Ask your prescriber for an electronic or paper prescription.
• Request the DIN or exact product name to speed pharmacist verification.
• If discharged from hospital, bring the discharge summary to your community pharmacist.

How long can I take ketorolac?

The maximum recommended duration is five days for oral and parenteral therapy per product monograph.

Longer use increases the risk of gastrointestinal bleeding and kidney injury.

Can I take Toradol with my blood thinner?

Avoid combining ketorolac with anticoagulants unless a specialist authorises it.

The combination increases bleeding risk and requires close monitoring.

Will provincial drug plans cover it?

Coverage varies by province and setting.

Hospital inpatient use is typically covered, but outpatient coverage often requires exceptional status or specific formulary listings.

Guidelines For Proper Use (Pharmacist & Provincial Authority Tips)

Clinicians and pharmacists often ask what to emphasise when counselling patients discharged with a short course of ketorolac.

Best practices include using the lowest effective dose for the shortest duration (≤5 days), avoiding use in high‑risk patients and including ketorolac as part of a multimodal analgesic plan rather than as lone therapy when possible.

• Pharmacist Checklist: Confirm indication; verify DIN and product monograph; counsel in English and French on dosing, interactions and side effects; advise against alcohol and concurrent OTC NSAIDs; provide written instructions at discharge.
• Follow‑Up: Arrange renal function monitoring for at‑risk patients and telephone or telepharmacy follow‑up for remote discharges.

Monitoring Parameters:

Blood Pressure: Monitor in patients with cardiovascular disease or on ACE inhibitors/diuretics.

Renal Labs: Check creatinine in patients with baseline CKD risk factors or diuretic/ACE inhibitor therapy.

GI Signs: Counsel to report black tarry stools, vomiting blood or severe abdominal pain immediately.

Provide a bilingual handout template that lists indication, dose schedule, maximum duration, interactions, and emergency signs to watch for.

Delivery Across Canada (English)